[1] Rubio J, Kyttaris VC. Undifferentiated connective tissue disease: comprehensive review. Connectivetissue sisease: Comprehensive review. Curr Rheumatol Rep, 2023, 25(5): 98-106. [2] Mosca M, Neri R, Bombardieri S. Undifferentiated connective tissue diseases (UCTD): a review of the literature and a proposal for preliminary classification criteria. Clin Exp Rheumatol, 1999,17(5):615-620. [3] 莫颖倩, 严青, 叶霜, 等. 未分化结缔组织病和混合性结缔组织病的诊疗规范. 中华内科杂志, 2022, 61(10): 1119-1127. [4] Radin M, Rubini E, Cecchi I, et al. Disease evolution in a long-term follow-up of 104 undifferentiated connective tissue disease patients. Clin Exp Rheumatol, 2022, 40(3): 575-580. [5] Drehmel KR, Erickson AR, England BR, et al. Applying SLICC and ACR/EULAR systemic lupus erythematosus classification criteria in a cohort of patients with undifferentiated connective tissue disease. Lupus, 2021, 30(2): 280-284. [6] Sciascia S, Roccatello D, Radin M, et al. Differentiating between UCTD and early-stage SLE: from definitions to clinical approach. Nat Rev Rheumatol, 2022,18(1):9-21. [7] Garcia-Gonzalez M, Rodriguez-Lozano B, Bustabad S, et al. Undifferentiated connective tissue disease: predictors of evolution into definite disease. Clin Exp Rheumatol, 2017, 35(5): 739-745. [8] Radin M, Cecchi I, Barinotti A, et al. Identifying subsets of patients with undifferentiated connective tissue disease: Results from a prospective, real-world experience using particle-based multi-analyte technology. Autoimmun Rev, 2023, 22(5): 103298. |